Brief: Oasis Management - Filed Shareholder Derivative Lawsuit Against Kobayashi Pharmaceutical Directors
07/04/2025 24:30
April 7 (Reuters) - Kobayashi Pharmaceutical Co Ltd 4967.T: OASIS MANAGEMENT: FILED SHAREHOLDER DERIVATIVE LAWSUIT AGAINST KOBAYASHI PHARMACEUTICAL DIRECTORS OASIS MANAGEMENT:LAWSUIT INTENDS TO RECOVER APPROXIMATELY JPY 13.5 BILLION IN DAMAGES FOR KOBAYASHI PHARMACEUTICAL AND ITS SHAREHOLDERS Source text: [ID:] Further company coverage: 4967.T (Reporting by Tokyo Newsroom) ((+81345201189;))
Recent news on Kobayashi Pharmaceutical
See all newsNotice Regarding Certain Media Reports
Brief: Japan's Kobayashi Pharmaceutical Considering Going Private Under Japan-UK Investment Fund Consortium, Bloomberg News Says
Brief: Oasis Management Raises Stake In Kobayashi Pharmaceutical To 14.41% From 13.37%, Filing Shows
Table: Kobayashi Pharmaceutical - 6-MTH group results
Brief: Oasis Management Company Is Making Shareholder Proposal To Kobayashi Pharmaceutical Co, Filing Shows